Emerging Applications Clinical Developments Patient Selection and Optimization Successful treatment requires careful patient selection and protocol optimization
Our team considers an array of factors when determining the potential weight loss success of our patients with lipotropic injections
Iwamoto, T., Hosoda, K., Hirano, R., Kurata, H., Matsumoto, A., Miki, W., & Kondo, K
Individuals struggling with fat loss or body composition Those experiencing low energy or poor recovery Patients with disrupted sleep patterns Active adults seeking improved performance and recovery Individuals focused on healthy aging and longevity Growth hormone naturally declines with age
GRAS Designation & Food Substance Classification In 2023, AOD-9604 received "Generally Recognized as Safe" (GRAS) designation from the FDA when submitted as a food substance or dietary supplement ingredient